United States Drugs for Respiratory Syncytial Virus (RSV) Market Research Report Forecast 2017-2022

April 2017 | 117 pages | ID: U13C9A8A521EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Drugs for Respiratory Syncytial Virus (RSV) Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Drugs for Respiratory Syncytial Virus (RSV) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Drugs for Respiratory Syncytial Virus (RSV) market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Ablynx
ADMA Biologics
Agilvax
AlphaVax
AmVac
Aridis Pharmaceuticals
Artificial Cell Technologies
Astellas Pharma
AstraZeneca

United States Drugs for Respiratory Syncytial Virus (RSV) Market: Product Segment Analysis

Ribavirin
Bronchodilator
Type 3

United States Drugs for Respiratory Syncytial Virus (RSV) Market: Application Segment Analysis

Infants (Under 6 Month Old)
Babies & Children
Adults

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Drugs for Respiratory Syncytial Virus (RSV) Market Segmentation by Type
  1.2.1 United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2016
  1.2.1 Ribavirin
  1.2.2 Bronchodilator
  1.2.3 Type
1.3 Drugs for Respiratory Syncytial Virus (RSV) Market Segmentation by Application
  1.3.1 Drugs for Respiratory Syncytial Virus (RSV) Consumption Market Share by Application in 2016
  1.3.2 Infants (Under 6 Month Old)
  1.3.3 Babies & Children
  1.3.4 Adults
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MARKET COMPETITION BY MANUFACTURERS

3.1 United States Drugs for Respiratory Syncytial Virus (RSV) Production and Share by Manufacturers (2015 and 2016)
3.2 United States Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Drugs for Respiratory Syncytial Virus (RSV) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Drugs for Respiratory Syncytial Virus (RSV) Manufacturing Base Distribution, Production Area and Product Type
3.5 Drugs for Respiratory Syncytial Virus (RSV) Market Competitive Situation and Trends
  3.5.1 Drugs for Respiratory Syncytial Virus (RSV) Market Concentration Rate
  3.5.2 Drugs for Respiratory Syncytial Virus (RSV) Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Drugs for Respiratory Syncytial Virus (RSV) Production and Market Share by Type (2012-2017)
4.2 United States Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2012-2017)
4.3 United States Drugs for Respiratory Syncytial Virus (RSV) Price by Type (2012-2017)
4.4 United States Drugs for Respiratory Syncytial Virus (RSV) Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MARKET ANALYSIS BY APPLICATION

5.1 United States Drugs for Respiratory Syncytial Virus (RSV) Consumption and Market Share by Application (2012-2017)
5.2 United States Drugs for Respiratory Syncytial Virus (RSV) Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MANUFACTURERS ANALYSIS

6.1 Ablynx
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 ADMA Biologics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Agilvax
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 AlphaVax
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 AmVac
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Aridis Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Artificial Cell Technologies
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Astellas Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 AstraZeneca
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MANUFACTURING COST ANALYSIS

7.1 Drugs for Respiratory Syncytial Virus (RSV) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Respiratory Syncytial Virus (RSV)

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drugs for Respiratory Syncytial Virus (RSV) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Respiratory Syncytial Virus (RSV) Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MARKET FORECAST (2017-2022)

11.1 United States Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue Forecast (2017-2022)
11.2 United States Drugs for Respiratory Syncytial Virus (RSV) Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Drugs for Respiratory Syncytial Virus (RSV) Production Forecast by Type (2017-2022)
11.4 United States Drugs for Respiratory Syncytial Virus (RSV) Consumption Forecast by Application (2017-2022)
11.5 Drugs for Respiratory Syncytial Virus (RSV) Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure United States Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2016
Table Application of Drugs for Respiratory Syncytial Virus (RSV)
Figure United States Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application in 2016
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table United States Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 United States Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table United States Market Drugs for Respiratory Syncytial Virus (RSV) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Respiratory Syncytial Virus (RSV) Average Price of Key Manufacturers in 2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Market Share of Top 3 Manufacturers
Figure Drugs for Respiratory Syncytial Virus (RSV) Market Share of Top 5 Manufacturers
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales by Type (2012-2017)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2012-2017)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Type in 2015
Table United States Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2012-2017)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2012-2017)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Price by Type (2012-2017)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2012-2017)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales by Application (2012-2017)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application (2012-2017)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Sales Market Share by Application in 2016
Table United States Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2012-2017)
Table Ablynx Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ablynx Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table Ablynx Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table ADMA Biologics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ADMA Biologics Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table ADMA Biologics Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table Agilvax Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Agilvax Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table Agilvax Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table AlphaVax Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AlphaVax Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table AlphaVax Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table AmVac Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AmVac Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table AmVac Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table Aridis Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Aridis Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table Aridis Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table Artificial Cell Technologies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Drugs for Respiratory Syncytial Virus (RSV) Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Drugs for Respiratory Syncytial Virus (RSV) Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Respiratory Syncytial Virus (RSV)
Figure Manufacturing Process Analysis of Drugs for Respiratory Syncytial Virus (RSV)
Figure Drugs for Respiratory Syncytial Virus (RSV) Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Respiratory Syncytial Virus (RSV) Major Manufacturers in 2016
Table Major Buyers of Drugs for Respiratory Syncytial Virus (RSV)
Table Distributors/Traders List
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Production and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate Forecast (2017-2022)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Production Forecast by Type (2017-2022)
Table United States Drugs for Respiratory Syncytial Virus (RSV) Consumption Forecast by Application (2017-2022)